ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
1-Year Est. Return
41.76%
This Fund
S&P 500
1 Year Est. Return
-41.76%
AUM
$37.1M
AUM Growth
-$21.3M
(-36%)
Holding
15
Top Buys
| 1 | +$1.15M | |
| 2 | +$966K | |
| 3 | +$501K | |
| 4 |
Protagonist Therapeutics
PTGX
|
+$214K |
Top Sells
| 1 | +$4.46M | |
| 2 | +$2.86M | |
| 3 | +$2.53M | |
| 4 |
Kymera Therapeutics
KYMR
|
+$1.64M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
+$592K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
DELISTED
Blueprint Medicines
BPMC
| $7.43M | 20.03% |
83,926
-45,674
|
|
||
2
Arrowhead Research
ARWR
$7.92B
| $7.01M | 18.9% |
550,130
-157,459
|
|
||
|
3
Protagonist Therapeutics
PTGX
$6.34B
| $3.95M | 10.65% |
81,692
+5,100
|
|
||
|
4
Kymera Therapeutics
KYMR
$6.26B
| $3.79M | 10.22% |
138,521
-45,000
|
|
||
5
Precision BioSciences
DTIL
$160M
| $3.46M | 9.34% |
726,149
+189,773
|
|
||
6
Arvinas
ARVN
$672M
| $2.53M | 6.83% |
360,766
+32,000
|
|
||
7
Regenxbio
RGNX
$439M
| $1.94M | 5.23% |
271,302
-75,000
|
|
||
8
Adicet Bio
ACET
$65M
| $1.85M | 5% |
153,512
-4,688
|
|
||
|
BCYC
9
Bicycle Therapeutics
BCYC
$304M
| $1.46M | 3.93% |
171,695
-50,216
|
|
||
10
Immatics
IMTX
$1.27B
| $1.38M | 3.71% |
304,902
-69,000
|
|
||
|
RPTX
11
DELISTED
Repare Therapeutics
RPTX
| $1.28M | 3.44% |
1,293,715
|
|
||
12
Zymeworks
ZYME
$1.78B
| $1.01M | 2.71% |
+84,482
|
|
||
13
Amgen
AMGN
$189B
| – | – |
0
|
|
||
|
SLN
14
Silence Therapeutics
SLN
$273M
| – | – |
-367,214
|
|
||
15
Sutro Biopharma
STRO
$343M
| – | – |
-50
|
|